TEVA PHARMACEUTICAL INDUSTRIES LTD reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,493 SEC EDGAR filings since 02 Feb 1996

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
27 Dec 2017
Reporting date
27 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
18 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
15 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

FORM 6-K

Filing date
14 Dec 2017
Reporting date
14 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
13 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
12 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
11 Dec 2017
Reporting date
11 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
29 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
27 Nov 2017
Reporting date
27 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-55457

SC 13D/A

Filing date
13 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
02 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K

Filing date
02 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-55457

SC 13D/A

Filing date
01 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
01 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
31 Oct 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
30 Oct 2017
Reporting date
30 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .